Solipharma LLC
Hangzhou, Zhejiang, CN· latest recorded location
Solipharma LLC is named on 0 US grants and 11 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 0
- Published applications
- 11
- Inventors
- 10
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 6 |
| 2020 | 0 | 3 |
By publication year.
Technology areas
Share of 11 documents
Recent patents
No granted patents yet.
- Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof20 Aug 2020US 2020/0262839 A1
- Ozanimod addition salt crystal, preparation method, pharmaceutical composition, and uses30 Jan 2020US 2020/0031784 A1
- Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4h-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition16 Jan 2020US 2020/0017470 A1
- Crystal form of acp-196, preparation method therefor and pharmaceutical composition thereof19 Dec 2019US 2019/0382405 A1
- Fenofibrate crystalline form and manufacturing method thereof5 Sep 2019US 2019/0270694 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.